International Journal of Biological Macromolecules, Год журнала: 2024, Номер 280, С. 135574 - 135574
Опубликована: Сен. 11, 2024
Язык: Английский
International Journal of Biological Macromolecules, Год журнала: 2024, Номер 280, С. 135574 - 135574
Опубликована: Сен. 11, 2024
Язык: Английский
Acta Pharmaceutica Sinica B, Год журнала: 2025, Номер unknown
Опубликована: Март 1, 2025
Язык: Английский
Процитировано
1ACS Applied Materials & Interfaces, Год журнала: 2025, Номер unknown
Опубликована: Апрель 29, 2025
Developing oral drug delivery systems is promising for ulcerative colitis (UC). However, the key challenges, including formulation degradation under harsh gastric conditions, poor targeting efficiency, and limited colonic residence, lead to therapeutic efficacy that still needs be tackled. Effective treatment requires a safe, efficacious, enzyme- pH-responsive, biomucoadhesive system overcome these challenges. Therefore, we have developed chitosan-armored 1,2-dimyristoyl-sn-glycero-3-phosphoglycerol (DMPG) nanoliposomes amalgamated with synthesized beta-sitosterol-sinapic acid (Be-S) conjugate, further encapsulated 3,4-methylenedioxy-β-nitrostyrene (MNS) as NLRP3 inhibitor, termed C@MN@DMBe-S, limitation of free MNS sinapic acid. Formulated by thin-film hydration method processed through extrusion, unilamellar liposomes demonstrated structural stability mucoadhesive properties due chitosan coating. This configuration protected from acidic environment allowed retention in inflamed colon 48 h. The enzyme-responsive C@MN@DMBe-S nanoliposome releases at site via esterase activity, providing sustained controlled release MNS. synergistic action delivers antioxidant anti-inflammatory effects while influencing gut microbiota composition releasing short-chain fatty acids. Moreover, investigations revealed exhibited superior compared when administered orally. effectively downregulated NF-κB, NLRP3, Caspase-1, IL-1β expression upregulating MUC5AC expression, indicating enhanced protective thereby promoting mucosal healing. In addition, was found regulate immune cell downregulate neutrophil infiltration. armor- strategy elucidates impact nanomedicines on mitigating UC an effective treatment.
Язык: Английский
Процитировано
1Food Hydrocolloids, Год журнала: 2024, Номер 160, С. 110732 - 110732
Опубликована: Окт. 11, 2024
Язык: Английский
Процитировано
3Journal of Pharmaceutical Analysis, Год журнала: 2025, Номер unknown, С. 101226 - 101226
Опубликована: Фев. 1, 2025
Язык: Английский
Процитировано
0Materials Today Bio, Год журнала: 2025, Номер 31, С. 101609 - 101609
Опубликована: Фев. 25, 2025
Язык: Английский
Процитировано
0Colloids and Surfaces B Biointerfaces, Год журнала: 2025, Номер 253, С. 114722 - 114722
Опубликована: Апрель 18, 2025
Язык: Английский
Процитировано
0International Journal of Biological Macromolecules, Год журнала: 2024, Номер 280, С. 135574 - 135574
Опубликована: Сен. 11, 2024
Язык: Английский
Процитировано
1